Why is it important to check the urine albumin-to-creatinine ratio (ACR) in patients with Restless Legs Syndrome (RLS)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 2, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Urine Albumin-to-Creatinine Ratio in Restless Legs Syndrome

Checking urine albumin-to-creatinine ratio (ACR) in patients with Restless Legs Syndrome (RLS) is important primarily to screen for chronic kidney disease (CKD), which is a common secondary cause of RLS and significantly impacts mortality and morbidity outcomes.

Connection Between RLS and Kidney Disease

Kidney disease, particularly end-stage renal disease (ESRD), is strongly associated with RLS for several reasons:

  • Uremic RLS (RLS secondary to kidney disease) has a much higher prevalence (12-62%) compared to the general population (3-9%) 1
  • RLS in dialysis patients is associated with:
    • Higher risk of cardiovascular events (64.5% with RLS vs. 39.1% without RLS) 1
    • Increased mortality (32.3% with RLS vs. 14.5% without RLS) 1
    • More severe symptoms requiring higher medication doses 2

Why Check ACR Specifically

  1. Early Detection of Kidney Disease:

    • ACR is recommended as part of the laboratory evaluation for RLS to rule out secondary causes 3
    • European Urology guidelines specifically list urine ACR as part of the recommended testing for patients with suspected sleep disorders including RLS 4
  2. Staging and Risk Assessment:

    • ACR helps classify CKD stages and assess progression risk 4
    • Even low levels of albuminuria are associated with increased cardiovascular and kidney disease risk 4
    • The combination of ACR and eGFR provides a more comprehensive assessment of kidney function and risk 4
  3. Treatment Implications:

    • Patients with RLS and kidney disease require different treatment approaches:
      • Gabapentin is recommended as first-line for RLS patients with CKD or ESRD 3
      • Iron supplementation protocols differ for RLS patients with kidney disease 3

Clinical Approach to ACR Testing in RLS

When to Check ACR in RLS Patients:

  • At initial evaluation of all patients with RLS symptoms 3
  • Particularly important in patients with:
    • Risk factors for kidney disease (diabetes, hypertension)
    • Symptoms suggestive of more severe RLS (continuous symptoms vs. intermittent) 1
    • Poor response to standard RLS treatments 2

Interpreting ACR Results:

  • Normal ACR: <30 mg/g creatinine 4
  • Moderately increased: 30-299 mg/g creatinine 4
  • Severely increased: >300 mg/g creatinine 4

Management Implications:

  • If ACR is elevated:
    • Further kidney function evaluation is warranted (eGFR, complete workup)
    • Consider nephrology referral if ACR >300 mg/g or eGFR <30 mL/min/1.73m² 4
    • Adjust RLS treatment approach to account for kidney disease 3

Clinical Significance

The presence of albuminuria in RLS patients has significant implications:

  1. Mortality Risk: RLS patients with kidney disease have significantly higher mortality (up to 55.6% in those with continuous RLS symptoms) 1

  2. Cardiovascular Risk: RLS with kidney disease increases cardiovascular event risk by 64.5% compared to 39.1% in those without RLS 1

  3. Treatment Resistance: Uremic RLS often requires higher medication doses and has decreased response to dopaminergic agonists 2

  4. Disease Progression: Uremic RLS deteriorates faster and becomes more severe than idiopathic RLS 2

By identifying kidney disease through ACR testing in RLS patients, clinicians can implement appropriate treatment strategies that address both conditions and potentially reduce mortality and morbidity risks.

References

Research

Restless legs syndrome enhances cardiovascular risk and mortality in patients with end-stage kidney disease undergoing long-term haemodialysis treatment.

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2011

Research

Clinical characteristics of restless legs syndrome in end-stage renal failure and idiopathic RLS patients.

Movement disorders : official journal of the Movement Disorder Society, 2008

Guideline

Restless Legs Syndrome Diagnosis and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.